Citius pharmaceuticals to present at the ld micro invitational xiv investor conference

Cranford, n.j. , april 4, 2024 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that chairman and ceo leonard mazur will present at the 14th annual ld micro invitational investor conference being held april 8-9, 2024, in new york city.
CTXR Ratings Summary
CTXR Quant Ranking